Veeva Systems Inc
F:VEE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Veeva Systems Inc
F:VEE
|
US |
|
N
|
Netflix Inc
DUS:NFC
|
US |
|
Cemex SAB de CV
NYSE:CX
|
MX |
|
B
|
BNP Paribas SA
MIL:BNP
|
FR |
|
Perella Weinberg Partners
NASDAQ:PWP
|
US |
|
M
|
Mastercard Inc
SWB:M4I
|
US |
|
C
|
Curro Holdings Ltd
JSE:COH
|
ZA |
|
LVMH Moet Hennessy Louis Vuitton SE
PAR:MC
|
FR |
|
Intesa Sanpaolo SpA
OTC:IITSF
|
IT |
|
Q
|
Qingdao Port International Co Ltd
XMUN:0QP
|
CN |
|
CrowdStrike Holdings Inc
BMV:CRWD
|
US |
|
G
|
General Electric Co
PAR:GNE
|
US |
|
Nippon Building Fund Inc
OTC:NBFJF
|
JP |
|
Alexandria Real Estate Equities Inc
NYSE:ARE
|
US |
|
S
|
Southern Co
XMUN:SOT
|
US |
|
Pinterest Inc
NYSE:PINS
|
US |
|
Liberty Media Corp
NASDAQ:LLYVA
|
US |
|
B
|
Barrick Gold Corp
XMUN:ABR
|
CA |
|
M
|
Mercadolibre Inc
XBER:MLB1
|
AR |
Veeva Systems Inc
Veeva Systems makes cloud software for companies in pharmaceuticals, biotechnology, and medical devices. Its tools help customers manage drug sales, clinical trials, regulatory documents, quality records, and safety data. Instead of selling broad business software, Veeva focuses on the tightly regulated life sciences market, where companies need systems built around compliance and traceability. The company sells its products mainly as subscriptions, with some professional services to help customers set them up and connect them to existing systems. Its main customers are drug makers, biotech firms, and medtech companies, along with some partners in the wider life sciences supply chain. These customers use Veeva’s software to run key work processes across research, development, and commercial operations. What sets Veeva apart is its deep specialization. Life sciences companies face strict rules, long product cycles, and heavy documentation needs, so they often prefer software built specifically for that environment rather than generic enterprise tools. That makes Veeva an important software layer in the industry, sitting between the companies that develop medicines and the teams that bring those products to market.
Veeva Systems makes cloud software for companies in pharmaceuticals, biotechnology, and medical devices. Its tools help customers manage drug sales, clinical trials, regulatory documents, quality records, and safety data. Instead of selling broad business software, Veeva focuses on the tightly regulated life sciences market, where companies need systems built around compliance and traceability.
The company sells its products mainly as subscriptions, with some professional services to help customers set them up and connect them to existing systems. Its main customers are drug makers, biotech firms, and medtech companies, along with some partners in the wider life sciences supply chain. These customers use Veeva’s software to run key work processes across research, development, and commercial operations.
What sets Veeva apart is its deep specialization. Life sciences companies face strict rules, long product cycles, and heavy documentation needs, so they often prefer software built specifically for that environment rather than generic enterprise tools. That makes Veeva an important software layer in the industry, sitting between the companies that develop medicines and the teams that bring those products to market.
Results: Total revenue for the quarter was $836 million and non-GAAP operating income was $366 million; full-year revenue was $3.195 billion with non-GAAP operating income of $1.434 billion.
Guidance: Management set a FY26→FY27 total revenue growth guide of 13% and expects subscription growth of ~13% vs. normalized billings growth of ~11%; guidance assumes no significant change in the macro environment.
CRM momentum: Vault CRM deployments continue to accelerate (roughly 140 customers live) and management remains on track for ~14 of the top 20 customers to standardize on Vault CRM; end-of-support for the competing product was pulled forward to December 2029.
AI positioning: Customers want AI tightly integrated with core systems; Veeva sees itself as a trusted, industry-specific partner building packaged AI agents (commercial content is furthest along) and expects AI to be accretive over the coming years but not materially in FY27.
R&D & services: Strong execution in R&D (notably RTSM wins and eSource work) and professional services outperformance driven by business consulting, R&D services and CRM migrations; services hiring is underway and margins have remained profitable.
Crossix & comps: Crossix was a major driver of FY26 outperformance and while growth is expected to remain healthy, comps get tougher in FY27.
Management
Peter P. Gassner is a prominent figure in the technology and life sciences industries, best known as the co-founder and CEO of Veeva Systems Inc. Veeva Systems is a cloud-computing company focused on providing software solutions for the global life sciences industry. Under Gassner's leadership, the company has become a major player in the sector, known for its innovation and customer-centric approach. Gassner began his career in software development, working at IBM and later at Oracle, where he contributed significantly to the growth of their CRM division. His stint at Oracle honed his skills in enterprise software development and management, laying the groundwork for his future ventures. Before founding Veeva in 2007, Gassner also worked at Salesforce, where he was responsible for building the original technology team and was instrumental in developing the company’s platform. His strategic vision for Veeva Systems has always emphasized deep industry focus, product excellence, and customer success, which have been key factors in the company's expansion and efficacy. Under his guidance, Veeva has consistently grown its product offering, which includes applications for clinical trial management, regulatory compliance, quality management, and other areas critical to life sciences and pharmaceuticals. Peter Gassner's leadership style and business acumen have been widely recognized, earning him numerous accolades in the tech world. He is also known for advocating a genuine employee-centric culture and maintaining high standards of ethical business practices. Through his work with Veeva, Gassner has played a crucial role in transforming how pharmaceutical and biotech companies operate, ultimately aiming to improve patient outcomes globally.
Gassner began his career in software development, working at IBM and later at Oracle, where he contributed significantly to the growth of their CRM division. His stint at Oracle honed his skills in enterprise software development and management, laying the groundwork for his future ventures. Before founding Veeva in 2007, Gassner also worked at Salesforce, where he was responsible for building the original technology team and was instrumental in developing the company’s platform.
His strategic vision for Veeva Systems has always emphasized deep industry focus, product excellence, and customer success, which have been key factors in the company's expansion and efficacy. Under his guidance, Veeva has consistently grown its product offering, which includes applications for clinical trial management, regulatory compliance, quality management, and other areas critical to life sciences and pharmaceuticals.
Peter Gassner's leadership style and business acumen have been widely recognized, earning him numerous accolades in the tech world. He is also known for advocating a genuine employee-centric culture and maintaining high standards of ethical business practices.
Through his work with Veeva, Gassner has played a crucial role in transforming how pharmaceutical and biotech companies operate, ultimately aiming to improve patient outcomes globally.
Thomas D. Schwenger is a notable executive at Veeva Systems Inc., a cloud-computing company focused on the life sciences industry. As Chief Commercial Officer, he takes on the pivotal role of overseeing the company’s customer success and market expansion strategies. With a customer-centric approach, Schwenger is responsible for driving the company’s go-to-market functions including sales, services, and marketing. Before joining Veeva, Thomas Schwenger held several leadership roles that equipped him with extensive experience in managing large-scale operations and leading high-performance teams. He was previously affiliated with top-tier professional services firms, where he developed a strong foundation in strategic consulting and enterprise software solutions. Schwenger's educational background includes a focus on business and technology, which complements his professional experience in offering innovative solutions that align technology with business needs. His leadership at Veeva Systems is marked by a commitment to excellence and a drive to enhance the company’s value proposition to the life sciences sector. Through his strategic insights, Schwenger plays a crucial role in shaping the company's future trajectory and sustaining its competitive edge in the market.
Before joining Veeva, Thomas Schwenger held several leadership roles that equipped him with extensive experience in managing large-scale operations and leading high-performance teams. He was previously affiliated with top-tier professional services firms, where he developed a strong foundation in strategic consulting and enterprise software solutions.
Schwenger's educational background includes a focus on business and technology, which complements his professional experience in offering innovative solutions that align technology with business needs. His leadership at Veeva Systems is marked by a commitment to excellence and a drive to enhance the company’s value proposition to the life sciences sector. Through his strategic insights, Schwenger plays a crucial role in shaping the company's future trajectory and sustaining its competitive edge in the market.
